Prevalence of ESBLs and Biofilm Formation in Escherichia coli Isolated from Urinary Tract Infection in Isfahan, Iran

Document Type : Original Research

Authors
E. Haghighifar
A. A. Rezaei
Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
10.52547/iem.8.3.223
Abstract
Backgrounds: Uropathogenic Escherichia coli is a Gram-negative bacillus that is the most common cause of urinary tract infection. E. coli has the ability to produce biofilm as an important virulence factor. Due to the lack of sufficient information about ESBL resistance genes in this geographical area, this study aimed to investigate the prevalence of ESBLs in E. coli isolates to increase our knowledge about the role of these genes and biofilm formation in inducing resistance.

Materials & Methods: 139 E. coli strains were isolated from urine samples. Antibiotic susceptibility testing was performed for the isolates by disk diffusion method. ESBL production was confirmed using double-disk synergy test. Molecular detection of ESBL genes was performed using PCR. Biofilm formation assay was performed by microtiter plate method.

Findings: The most effective antibiotic against this bacterium was nitrofurantoin. Multidrug resistance was observed in 119 (85.6%) isolates. ESBL phenotype was detected in 93 (66.9%) isolates. The PCR test results showed that blaCTX, blaVEB, and blaTEM were positive in 45 (32.4%), 87 (62.6%), and 10 (7.2%) isolates, respectively. The biofilm formation assay results revealed that 65 (46.8%), 58 (41.7%), 10 (7.2%), and six (4.3%) isolates were non-, weak, moderate, and strong biofilm producers, respectively.

Conclusions: The high prevalence of ESBL genes is a public health concern in this region because they could be transmitted to other susceptible bacteria and induce resistance. This study showed that biofilm production could increase antibiotic resistance.

Keywords

Subjects

Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res. 2014;139(6):945-8.
[2] Emody L, Kerényi M, Nagy G. Virulence factors of uropathogenic Escherichia coli. Int J Antimicrob. 2003;22(Suppl 2):29-33.
[3] Mishra MP, Debata NK, Padhy RN. Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian. Asian Pac J Trop Biomed. 2013;3(4):315-24
[4] Laupland K, Ross T, Pitout J, Church D, Gregson D. Community-onset urinary tract infections: A population-based assessment. Infection. 2007;35(3:(150-3.
[5] Komijani M, Bouzari M, Rahimi F. Detection of blaTEM, blaSHV, and blaCTX-M antibiotic resistance genes in Escherichia coli isolates from infected wounds. Med Lab J. 2017;11(2):30-5.
[6] Johora FT, Ahmed Z. Bacteriological study of post-operative abdominal wound infection-a case study. Bangladesh J Medical Sci. 2013;12(1):86-90.
[7] Ramadan AA, Abdelaziz NA, Amin MA, Aziz RK. Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli. Sci Rep. 2019;9(1):1-2.
[8] Heidary M, Momtaz H, Madani M. Characterization of diarrheagenic antimicrobial resistant Escherichia coli isolated from pediatric patients in Tehran, Iran. Iran Red Crescent Med J. 2014;16(4):e12329.
[9] Lu TK, Koeris MS. The next generation of bacteriophage therapy. Curr Opin Microbiol. 2011;14(5):524-31.
[10] Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
[11] SarojGolia D, Hittinahalli V, Karjigi SK, Reddy KM. Correlation between biofilm formation of uropathogenic Escherichia coli and its antibiotic resistance pattern. J Evol Med Den Sci. 2012;1(3):166.
[12] Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology, and treatment. Saudi J Biol Sci. 2015;22(1):90-101.
[13] Raya S, Belbase A, Dhakal L, Govinda Prajapati K, Baidya R. In-vitro biofilm formation and antimicrobial resistance of Escherichia coli in diabetic and nondiabetic patients. Biomed Res Int. 2019;2019.
[14] Gawad WE, Helmy OM, Tawakkol WM, Hashem AM. Antimicrobial resistance, biofilm formation, and phylogenetic grouping of uropathogenic Escherichia coli isolates in Egypt: The role of efflux pump-mediated resistance. Jundishapur J Microbiol. 2018;11(2):e14444.
[15] Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence. 2013;4(3):223-9.
[16] Tiba MR, Yano T, da Silva Leite D. Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis. Rev Inst Med Trop Sao Paulo. 2008;50(5):255-60.
[17] Patel JB, Cockerill FR, Bradford PA. Performance standards for antimicrobial susceptibility testing: Twenty-fifth informational supplement. Wayne: Clinical and Laboratory Standards Institute; 2015.
[18] Anvarinejad M, Pouladfar GR, Pourabbas B, Shahidi MA, Rafaatpour N, Dehyadegari MA, et al. Detection of Salmonella spp. with the BACTEC 9240 automated blood culture system in 2008-2014 in southern Iran (Shiraz): Biogrouping, MIC, and antimicrobial susceptibility profiles of isolates. Jundishapur J Microbiol. 2016;9(4):e26505.
[19] Chen J, Griffiths M. PCR differentiation of Escherichia coli from other Gram‐negative bacteria using primers derived from the nucleotide sequences flanking the gene encoding the universal stress protein. Lett Appl Microbiol. 1998;27(6):369-71.
[20] Tahanasab Z, Mobasherizadeh S, Moghadampour M, Rezaei A, Maleki N, Faghri J. High prevalence of multiple drug resistance among ESBLs-producing Klebsiella pneumoniae isolated from hospitalized patients in Isfahan, Iran. J Med Bacteriol. 2016;5(5-6):29-38.
[21] Maleki N, Tahanasab Z, Mobasherizadeh S, Rezaei A, Faghri J. Prevalence of blaCTX-M and TEM β-lactamases in Klebsiella pneumoniae isolates from patients with urinary tract infection, Al-Zahra hospital, Isfahan, Iran. Adv Biomed Res. 2018;7:10.
[22] Moghadampour M, Rezaei A, Faghri J. The emergence of blaOXA-48 and blaNDM among ESBL-producing Klebsiella pneumoniae in clinical isolates of a tertiary hospital in Iran. Acta Microbiol Immunol Hung. 2018;65(3):335-44.
[23] Hedlund M, Duan RD, Nilsson A, Svensson M, Karpman D, Svanborg C. Fimbriae, transmembrane signaling, and cell activation. J Infect Dis. 2001;183(Suppl 1):S47-50.
[24] Anusha SU, Sundar SK. ESBL& biofilm-producing uropathogenic pathogens and their antibiotic susceptibility patterns from urinary tract infection of patients at namakkal, tamil nadu: A case study. J Nat Remedies. 2020;21(8):381-7.
[25] Tayal RA, Baveja SM, De AS. Analysis of biofilm formation and antibiotic susceptibility pattern of uropathogens in patients admitted in a tertiary care hospital in India. Int J Health Allied Sci. 2015;4(4):247-52
[26] Tang X, Zhao Z, Hu J, Wu B, Cai X, He Q, et al. Isolation, antimicrobial resistance, and virulence genes of Pasteurella multocida strains from swine in China. J Clin Microbiol. 2009;47(4):951-8.
[27] Sharif MR, Alizargar J, Sharif A. Antimicrobial resistance among Gram-negative bacteria isolated from different samples of patients admitted to a university hospital in Kashan, Iran. Adv Biol Res. 2013;7(5):199-202.
[28] Fallah F, Karimi A, Goudarzi M, Shiva F, Navidinia M, Hadipour Jahromi M, et al. Determination of integron frequency by a polymerase chain reaction–restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections. Microb Drug Resist. 2012;18(6):546-9.
[29] Ibrahim M, Bilal N, Hamid M. Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan. Afr Health Sci. 2012;12(3):368-75.
[30] Farzi S, Ranjbar R, Niakan M, Ahmadi MH. Molecular characterization of antibiotic resistance associated with blaTEM and blaCTX-M ESBL in uropathogenic E. coli strains isolated from outpatients. Iran J Pathol. 2021;16(4):386-91.
[31] Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of blaCTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol. 2004;42(12):5715-21.
[32] Farshad S, Japoni N, Hosseini MJ. Low distribution of integrons among multidrug resistant E. coli strains isolated from children with community-acquired urinary tract infections in Shiraz. Pol J Microbiol. 2008;57(3):193-8.
[33] Rodriguez-Bano J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Escherichia coli producing blaSHV-type extended-spectrum β-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother. 2009;63(4):781-4 .
[34] Risal G, Shrestha A, Kunwar S, Paudel G, Dhital R, Budha MB, et al. Detection of biofilm formation by Escherichia coli with its antibiogram profile. Int J Community Med Public Health. 2018;5(9):3771-5.
[35] Hassan A, Usman J, Kaleem F, Omair M, Khalid A, Iqbal M. Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis. 2011;15(4):305-11.
[36] Tajbakhsh E, Ahmadi P, Abedpour-Dehkordi E, Arbab-Soleimani N, Khamesipour F. Biofilm formation, antimicrobial susceptibility, serogroups, and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran. Antimicrob Resist Infect Control. 2016;5(1):1-8.
Infection Epidemiology and Microbiology
Volume 8, Issue 3
September 2022
Pages 223-231